Researchers are looking at new ways to deliver medicine directly into the bladder to treat non-muscle-invasive bladder cancer. These methods include mucoadhesive formulations and targeted delivery platforms. These systems are designed to help drugs stay in the bladder longer instead of being washed away by urine.
By keeping the medicine in place, these systems can improve how much of the drug reaches the bladder lining. Some targeted platforms may even help the medicine reach cancer tissues more directly. This could potentially allow doctors to use certain drugs that are usually too toxic for the rest of the body when given through the bloodstream.
It is important to note that this review summarizes current research and does not provide specific trial results. While these delivery methods show promise in early stages, they are not yet standard practice. Patients should talk to their doctors about the latest treatment options for bladder cancer.